Clinical Trails
Paul Brennan, IARC, France. Mutagenic and promotional determinants of human cancer risk.
List of trials
Allan Balmain, UCSF, USA. Mouse models of tumour initiation and promotion.
List of trials
Marc Gunter, IARC, France. Impact of changes in cancer risk factors on the molecular architecture of normal tissues.
List of trials
Emma Lundberg, KTH, Sweden. Multi-omics imaging of human tissue samples.
List of trials
Nuria Lopez-Bigas, IRB, Barcelona, Spain. Deriving molecular signatures of cancer promotion.
List of trials
Chris Counter, Duke University, USA. Exploiting genetically engineered mouse models to identify promoting events and Promolytics targets.
List of trials
Luke Gilbert, UCSF, USA. CRISPR functional genomics screens for analysis of gene targets that promote or restrain the activity of environmental tumour promoters.
List of trials
Calvin Kuo, Stanford, USA. Human organoids for analysis of mutation selection in human cancers.
List of trials
